Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.5%

7 terminated/withdrawn out of 127 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

22%

28 trials in Phase 3/4

Results Transparency

19%

13 of 70 completed trials have results

Key Signals

11 recruiting13 with results

Enrollment Performance

Analytics

N/A
44(46.8%)
Phase 4
22(23.4%)
Phase 2
14(14.9%)
Phase 1
8(8.5%)
Phase 3
6(6.4%)
94Total
N/A(44)
Phase 4(22)
Phase 2(14)
Phase 1(8)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (127)

Showing 20 of 127 trials
NCT07534462Not Yet Recruiting

Echocardiographic Assessment of the Effect of Impella on Biventricular Function

Role: collaborator

NCT07532473Not Yet Recruiting

REal World MAIA UK OutcomEs

Role: collaborator

NCT07507409Phase 4Not Yet Recruiting

Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients

Role: collaborator

NCT04165564Active Not Recruiting

DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers

Role: collaborator

NCT06965504Not ApplicableNot Yet Recruiting

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

Role: collaborator

NCT05972135Phase 2Recruiting

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Role: collaborator

NCT02248519Not ApplicableCompleted

Laparoscopic Versus Open Gastrectomy for Gastric Cancer

Role: collaborator

NCT07105059Phase 1Recruiting

A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

Role: collaborator

NCT04809103Phase 1Completed

Intratumoral Cisplatin for Resectable NSCLC

Role: collaborator

NCT07361055Not ApplicableEnrolling By Invitation

The Best Workflow for Paroxysmal Supraventricular Tachycardia Ablation With Zero-fluoroscopy

Role: collaborator

NCT07354217Phase 4Not Yet Recruiting

Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation

Role: collaborator

NCT00376571Phase 4Completed

Nordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions?

Role: collaborator

NCT00914199Not ApplicableCompleted

The Nordic Bifurcation Study III

Role: collaborator

NCT01496638Not ApplicableActive Not Recruiting

The Nordic-Baltic Bifurcation Study IV

Role: collaborator

NCT06173713Not ApplicableRecruiting

Emphasys Radiostereometric Analysis

Role: collaborator

NCT03620903Phase 2Active Not Recruiting

Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia

Role: collaborator

NCT07254455Not ApplicableNot Yet Recruiting

CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction)

Role: collaborator

NCT07225101Phase 4Recruiting

Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures

Role: collaborator

NCT07075510Phase 1Recruiting

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

Role: collaborator

NCT06993675Phase 2Recruiting

Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)

Role: collaborator